Nanobiotix S.A. (NBTX) stock
NBTXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NNBXF
$27.32+0.42 (+1.54%)
Close on Nov 19, 2026Market cap $1.32BP/E –Yield –
Nanobiotix net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2025 it was -€23.96M. The highest annual figure on record is -€23.96M in fiscal 2025.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -€23.96M | – |
| FY2024 | Dec 31, 2024 | -€68.13M | – |
| FY2023 | Dec 31, 2023 | -€39.70M | – |
| FY2022 | Dec 31, 2022 | -€57.04M | – |
| FY2021 | Dec 31, 2021 | -€47.06M | – |
| FY2020 | Dec 31, 2020 | -€33.59M | – |
| FY2019 | Dec 31, 2019 | -€50.92M | – |
| FY2018 | Dec 31, 2018 | -€30.35M | – |
See a number that looks wrong?